Skip to content

Cessation Clinical Trial

Cessation Clinical Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06806098
Enrollment
1555
Registered
2025-02-03
Start date
2024-12-05
Completion date
2025-11-17
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use Cessation

Keywords

Digital intervention

Brief summary

The Cessation Clinical Trial will investigate the effectiveness of a digital quit tobacco program in promoting abstinence from tobacco product use compared to usual care.

Interventions

BEHAVIORALTruth Initiative Digital Cessation Program

Truth Initiative's digital cessation program is a multimodal evidence-based, digital tobacco cessation program. Accessible on any web-enabled device, it was developed with the Mayo Clinic around tobacco dependence treatment guidelines, Social Cognitive Theory, and the Mayo Clinic model for engaging tobacco users in cessation treatment. It includes a personalized quit plan with AI-driven content recommendations, interactive exercises, educational videos, and emails; a dynamically tailored, bidirectional text message program; the longest-running online community dedicated to tobacco cessation; synchronous live chat coaching (sponsored version only); and pharmacotherapy decision support and delivery (sponsored version only).

BEHAVIORALUsual Care

Smokefree.gov is a web-based tobacco cessation platform run by the National Cancer Institute of the National Institutes of Health since 2003 and represents the current standard of care for digital tobacco cessation in the U.S. As of 2020, the SmokeFree.gov Initiative (SFGI) consisted of a multimodal suite of interventions - 6 mobile-optimized websites, 9 text messaging programs, 2 mobile apps, and social media platforms.

Sponsors

Truth Initiative
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Data collection staff will be blinded to study condition.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Current tobacco use (past 30-day use of one or more of the following: cigarettes, cigars, little cigars, cigarillos, e-cigarettes, or oral nicotine products) * US residence * Active text message plan (phase 2 only)

Exclusion criteria

* Age 25 or above (phase 2 only)

Design outcomes

Primary

MeasureTime frameDescription
30-day point prevalent abstinence7-months post randomization30-day point prevalent abstinence from user's primary product to quit indicated at enrollment

Secondary

MeasureTime frameDescription
Abstinence from all tobacco products7 months post randomizationAbstinence from any combustible tobacco product and any nicotine-containing product. Past 30-day abstinence will be measured for the following tobacco/nicotine products one by one and a combined total abstinence measure will be calculated based on these responses. Measurement item: In the past 30 days, which of the following products have you used at all (i.e., even a puff/hit)? Response options are Yes/No for each item. * Cigarettes * E-cigarettes * Chew * Dip * Nicotine pouches * Cigars/little cigars/cigarillos

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026